BeyondSpring Inc. Ordinary Shares
Symbol: BYSI (NASDAQ)
2.02
▼ (-1.23%) -0.025
Company Description:
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.
Key Stats
- Today's Open: $1.95
- Today's High: $2.189
- Today's Low: $1.825
- Today's Volume: 14.26K
- Yesterday Close: $2.04
- Yesterday High: $2.4
- Yesterday Low: $1.99
- Yesterday Volume: 67.63K
- Last Min Volume: 12
- Last Min High: $2.015
- Last Min Low: $2.015
- Last Min VWAP: $2.015
Company Profile
- Name: BeyondSpring Inc. Ordinary Shares
- Website: https://www.beyondspringpharma.com
- Listed Date: 2017-03-09
- Location: FLORHAM PARK, NJ
- Market Status: Active
- CIK Number: 0001677940
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $88.71M
- Round Lot: 100
- Outstanding Shares: 40.32M
- Asset Type: CS
RECENT FILINGS FOR BYSI
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-20 | 4 | View |
| 2025-10-15 | 4 | View |
| 2025-10-10 | 4 | View |
| 2025-10-07 | 4 | View |
| 2025-10-02 | 4 | View |
| 2025-09-29 | 4 | View |
| 2025-09-24 | 4 | View |
| 2025-09-23 | 8-K | View |
| 2025-09-19 | 4 | View |
| 2025-09-16 | 4 | View |
| 2025-09-16 | 8-K | View |
| 2025-09-11 | 4 | View |
| 2025-09-08 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-08-28 | 4 | View |
| 2025-08-25 | 4 | View |
| 2025-08-20 | 4 | View |
| 2025-08-18 | EFFECT | View |
| 2025-08-15 | 4 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
Latest News on BYSI